Palisade Bio (PALI) Other Non Operating Income (2014 - 2026)

Palisade Bio's (PALI) quarterly Other Non Operating Income came in at $1.1 million in Q1 2026, up 1318.52% year-on-year from $81000.0 in Q1 2025, and up 6.0% on a QoQ basis from $1.1 million in Q4 2025.

Palisade Bio (PALI) Other Non Operating Income (2014 - 2026) Analysis & Trends

Palisade Bio (PALI) has 13 years of Other Non Operating Income data on file, last reported at $1.1 million in Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 1318.52% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 541.14% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 196.77% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $1.1 million, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for PALI reached as high as $1.2 million in Q2 2022 and fell as low as $41000.0 in Q4 2024.
  • Historically, Other Non Operating Income has averaged $366823.5 across 5 years, with a median of $187000.0 in 2023.
  • Across the five-year window, Other Non Operating Income plunged 99.42% in 2022 and surged 2543.9% in 2025, its largest moves.
  • Year by year, Other Non Operating Income stood at $131000.0 in 2022, then surged by 42.75% to $187000.0 in 2023, then plunged by 78.07% to $41000.0 in 2024, then jumped by 2543.9% to $1.1 million in 2025, then rose by 6.0% to $1.1 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $59000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,734.26 Bn 65,733.97 Bn -
2 Nanobiotix 1,919.96 Bn 1,919.90 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 470.76 Bn 465.97 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.29 Bn 115.04 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.97 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.06 Bn 62.06 Bn -
8 Argenx Se 55.72 Bn 50.53 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn
10 Palisade Bio 418.28 Mn 285.65 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.15 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 59,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 81,000.00
Dec 31, 2024 41,000.00
Sep 30, 2024 112,000.00
Jun 30, 2024 133,000.00
Mar 31, 2024 147,000.00
Dec 31, 2023 187,000.00
Sep 30, 2023 190,000.00
Jun 30, 2023 219,000.00
Mar 31, 2023 189,000.00
Dec 31, 2022 131,000.00
Sep 30, 2022 426,000.00
Jun 30, 2022 1.23 Mn
Mar 31, 2022 794,000.00
Dec 31, 2021 22.75 Mn
Sep 30, 2021 20,000.00
Jun 30, 2021 5.13 Mn